ANGELA AUSTIN: Open Payments
NPI 1386396638 · DAVISON, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,120 in 61 payments from 10 companies in 2025. Trend: 2023 $227 · 2024 $869 · 2025 $1,120
Food & beverage: $1,120
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 15 | $214 |
| Alkermes, Inc. | 5 | $202 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $153 |
| ABBVIE INC. | 16 | $150 |
| Axsome Therapeutics, Inc. | 5 | $130 |
| Otsuka America Pharmaceutical, Inc. | 5 | $124 |
| Tris Pharma Inc | 3 | $53 |
| Lundbeck LLC | 2 | $47 |
| Janssen Pharmaceuticals, Inc | 1 | $24 |
| Supernus Pharmaceuticals, Inc. | 1 | $22 |
Products named: FANAPT, CAPLYTA, VRAYLAR, Auvelity, REXULTI, ARISTADA, LYBALVI, Onyda XR.
Industry payments across MI — which companies pay providers there.
